Log in
Enquire now
‌

US Patent 9724297 Sotalol compositions and uses of the same

Patent 9724297 was granted and assigned to Arbor Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Arbor Pharmaceuticals
Arbor Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
97242970
Patent Inventor Names
Jeffrey S. Kiel0
H. Greg Thomas0
Date of Patent
August 8, 2017
0
Patent Application Number
142426240
Date Filed
April 1, 2014
0
Patent Citations Received
‌
US Patent 11696902 Method of initiating and escalating sotalol hydrochloride dosing
0
‌
US Patent 11850222 Sotalol compositions and uses of the same
0
Patent Primary Examiner
‌
My-Chau T. Tran
0
Patent abstract

The present invention provides oral solutions containing sotalol hydrochloride which advantageously avoid swallowing while providing with improved stability. The present invention also relates to methods of using the oral solutions for treatment of diseases and disorders, such as delay in reoccurrence of atrial fibrillation/atrial flutter and/or ventricular arrhythmias.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9724297 Sotalol compositions and uses of the same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.